Cegedim Future Growth
Future criteria checks 4/6
Cegedim is forecast to grow earnings and revenue by 56.1% and 4.7% per annum respectively. EPS is expected to grow by 55.8% per annum. Return on equity is forecast to be 5.7% in 3 years.
Key information
56.1%
Earnings growth rate
55.8%
EPS growth rate
Healthcare Services earnings growth | 28.7% |
Revenue growth rate | 4.7% |
Future return on equity | 5.7% |
Analyst coverage | Low |
Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 703 | 20 | 31 | N/A | 1 |
12/31/2025 | 690 | 24 | 33 | 115 | 2 |
12/31/2024 | 652 | 21 | 28 | 101 | 2 |
12/31/2023 | 616 | -7 | 22 | 98 | N/A |
9/30/2023 | 602 | 1 | 26 | 104 | N/A |
6/30/2023 | 589 | 10 | 30 | 111 | N/A |
3/31/2023 | 572 | 12 | 20 | 99 | N/A |
12/31/2022 | 555 | 14 | 10 | 86 | N/A |
9/30/2022 | 548 | 14 | -7 | 64 | N/A |
6/30/2022 | 541 | 15 | -25 | 42 | N/A |
3/31/2022 | 533 | 21 | 3 | 69 | N/A |
12/31/2021 | 525 | 26 | 31 | 96 | N/A |
9/30/2021 | 518 | 24 | 36 | 106 | N/A |
6/30/2021 | 512 | 22 | 41 | 116 | N/A |
3/31/2021 | 504 | 16 | 39 | 113 | N/A |
12/31/2020 | 497 | 11 | 36 | 110 | N/A |
9/30/2020 | 496 | 10 | 28 | 98 | N/A |
6/30/2020 | 494 | 8 | 21 | 85 | N/A |
3/31/2020 | 499 | 5 | -6 | 57 | N/A |
12/31/2019 | 504 | 3 | -33 | 29 | N/A |
9/30/2019 | 495 | -1 | -8 | 54 | N/A |
6/30/2019 | 486 | -5 | 18 | 80 | N/A |
3/31/2019 | 477 | 0 | 41 | 102 | N/A |
12/31/2018 | 468 | 4 | 65 | 124 | N/A |
9/30/2018 | 464 | 8 | 41 | 100 | N/A |
6/30/2018 | 461 | 12 | 18 | 77 | N/A |
3/31/2018 | 459 | 10 | 16 | 75 | N/A |
12/31/2017 | 457 | 7 | 13 | 73 | N/A |
9/30/2017 | 452 | -13 | N/A | 82 | N/A |
6/30/2017 | 438 | -17 | N/A | 78 | N/A |
3/31/2017 | 435 | -12 | N/A | 76 | N/A |
12/31/2016 | 429 | -29 | N/A | 59 | N/A |
9/30/2016 | 438 | 13 | N/A | 52 | N/A |
6/30/2016 | 435 | 9 | N/A | 55 | N/A |
3/31/2016 | 432 | 1 | N/A | 9 | N/A |
12/31/2015 | 426 | 19 | N/A | 40 | N/A |
9/30/2015 | 364 | 0 | N/A | 89 | N/A |
6/30/2015 | 380 | -6 | N/A | 62 | N/A |
3/31/2015 | 399 | -4 | N/A | 130 | N/A |
12/31/2014 | 412 | -8 | N/A | 127 | N/A |
9/30/2014 | 161 | -26 | N/A | 132 | N/A |
6/30/2014 | 266 | -11 | N/A | 163 | N/A |
3/31/2014 | 377 | -5 | N/A | 143 | N/A |
12/31/2013 | 488 | -14 | N/A | 150 | N/A |
9/30/2013 | 906 | 21 | N/A | 131 | N/A |
6/30/2013 | 904 | 4 | N/A | 130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0DYQ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: 0DYQ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0DYQ is expected to become profitable in the next 3 years.
Revenue vs Market: 0DYQ's revenue (4.7% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: 0DYQ's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0DYQ's Return on Equity is forecast to be low in 3 years time (5.7%).